How Much Did iMedRIS Data Raise?
Funding & Key Investors

iMedRIS Data has solidified its market presence through a significant capital injection, bringing its cumulative financing to $350K. This latest infusion of $350K represents a major strategic investment, underscoring the firm's critical role in the research administration ecosystem. By securing this backing, the company is well-positioned to accelerate its enterprise-grade software development and expand its footprint among global research institutions.

The capital allocation reflects a broader trend of institutional confidence in platforms that digitize complex compliance and administrative workflows. As the research landscape becomes increasingly data-intensive, the demand for robust, cloud-native infrastructure has never been higher, providing a clear runway for the company to scale its operations.

What is iMedRIS Data?

iMedRIS Data
SoftwareHealthcare Software

iMedRIS Data operates at the intersection of research administration and cloud-based enterprise software. The company provides a comprehensive suite of connected applications designed to modernize the research lifecycle, from initial award management to complex compliance and vivarium oversight. By centralizing these disparate functions, the platform enables research organizations to mitigate operational risk while maximizing administrative efficiency. With a client base spanning over 700 global institutions, the firm has established itself as a foundational technology partner for academic, government, and private research entities seeking to optimize their internal planning and technology transfer processes.

How much funding has iMedRIS Data raised?

iMedRIS Data has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in iMedRIS Data

PPP

Public-Private Partnership

What's next for iMedRIS Data?

With this late-stage financing, iMedRIS Data is expected to prioritize the expansion of its product suite and the enhancement of its core compliance engines. The strategic roadmap likely includes deepening integration capabilities to support more complex, multi-institutional research collaborations and potentially pursuing inorganic growth through targeted acquisitions. As the company matures, the focus will shift toward sustaining its competitive advantage in the research administration sector by leveraging its data-rich environment to offer predictive insights for research leadership. This phase of growth is critical for cementing the company's status as the primary operating system for modern research organizations worldwide.

See full iMedRIS Data company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Business Intelligence (BI) SoftwareSoftwareBusiness ServicesProject Management
Content & Collaboration SoftwareSoftwareEducationTraining
Financial SoftwareSoftware
Healthcare SoftwareSoftwareBusiness Intelligence (BI) SoftwareCustomer Engagement Platforms

Frequently Asked Questions Regarding iMedRIS Data Financial Insights

What are the most recent funding rounds that iMedRIS Data has completed, and what were the funding rounds?
iMedRIS Data has recently completed 1 funding rounds: Debt on May 3, 2020.
What is the total amount of funding iMedRIS Data has raised to date?
iMedRIS Data has raised a total of $350K in funding to date.
How many funding rounds has iMedRIS Data completed?
iMedRIS Data has completed 1 funding rounds.
How much funding did iMedRIS Data raise in its most recent funding round?
iMedRIS Data raised $350K in its most recent funding round.
Who are the lead investors in iMedRIS Data's latest funding round?
The lead investor in iMedRIS Data's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in iMedRIS Data's history?
The largest funding round in iMedRIS Data's history was $350K.
See more information about iMedRIS Data